Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
Mostra el registre complet Registre parcial de l'ítem
- dc.contributor.author Mancebo Moreno, Gemma
- dc.contributor.author Solé-Sedeño, Josep Maria
- dc.contributor.author Membrive, Ismael
- dc.contributor.author Taus García, Álvaro
- dc.contributor.author Castells Zaragoza, Marta
- dc.contributor.author Serrano, Laia
- dc.contributor.author Carreras Collado, Ramón
- dc.contributor.author Miralpeix, Ester
- dc.date.accessioned 2021-07-21T07:24:01Z
- dc.date.available 2021-07-21T07:24:01Z
- dc.date.issued 2021
- dc.description.abstract The SARS-CoV-2 (COVID-19) pandemic has significantly impacted the management of patients with gynecologic cancers. Many centers have reduced access to routine visits to avoid crowded waiting areas and specially to reduce the infection risk for oncologic patients. The goal of this review is to propose a surveillance algorithm for patients with gynecologic cancers during the COVID-19 pandemic based on existing evidence and established guidelines. It is time to consider strategies based on telemedicine and to adapt protocols in this new era. We hereby propose a strategy for routine surveillance both during and beyond the pandemic.
- dc.format.mimetype application/pdf
- dc.identifier.citation Mancebo G, Solé-Sedeño JM, Membrive I, Taus A, Castells M, Serrano L, et al. Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19). Int J Gynecol Cancer. 2021 Jun; 31(6): 914-9. DOI: 10.1136/ijgc-2020-001942
- dc.identifier.doi http://dx.doi.org/10.1136/ijgc-2020-001942
- dc.identifier.issn 1048-891X
- dc.identifier.uri http://hdl.handle.net/10230/48258
- dc.language.iso eng
- dc.publisher BMJ Publishing Group
- dc.rights © BMJ Publishing Group, http://ijgc.bmj.com/content/31/6/914.long
- dc.rights.accessRights info:eu-repo/semantics/openAccess
- dc.subject.keyword Cervical cancer
- dc.subject.keyword Endometrial neoplasms
- dc.subject.keyword Gynecology
- dc.subject.keyword Ovarian cancer
- dc.title Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19)
- dc.type info:eu-repo/semantics/article
- dc.type.version info:eu-repo/semantics/acceptedVersion